In a prior study, cisplatin-resistant melanoma cells displayed a distinguishable elevated expression of (MRP2/ABCC2), which was reflected by a decrease in cisplatin cytotoxicity in terms of a decline in the drug’s ability to form intra-strand DNA cross-links. This evidence concerns the gene ABCC2 and melanoma.